Platelets are Hyperactivated but Show Reduced Glycoprotein VI Reactivity in COVID-19 Patients
Thromb Haemost
.
2021 Sep;121(9):1258-1262.
doi: 10.1055/a-1347-5555.
Epub 2021 Apr 14.
Authors
Valentine Léopold
1
2
3
,
Liza Pereverzeva
1
,
Alex R Schuurman
1
,
Tom D Y Reijnders
1
,
Anno Saris
1
,
Justin de Brabander
1
,
Christine C A van Linge
1
,
Renée A Douma
4
,
Osoul Chouchane
1
,
Rienk Nieuwland
5
,
W Joost Wiersinga
1
6
,
Cornelis van 't Veer
1
,
Tom van der Poll
1
6
Affiliations
1
Center of Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
2
Department of Anesthesiology and Critical Care, Paris University, Lariboisière Hospital, Paris, France.
3
Inserm UMR-S 942, Cardiovascular Markers in Stress Conditions (MASCOT), University of Paris, Paris, France.
4
Department of Internal Medicine, Flevo Hospital, Almere, The Netherlands.
5
Laboratory of Experimental Clinical Chemistry, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
6
Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
PMID:
33412595
DOI:
10.1055/a-1347-5555
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Platelets*
COVID-19*
Humans
Platelet Activation
Platelet Membrane Glycoproteins
SARS-CoV-2
Substances
Platelet Membrane Glycoproteins
Grants and funding
Institut Servier/Bourse à la mobilité
Institut National de la Santé et de la Recherche Médicale/Ecole de l'INSERM Liliane Bettencourt
Joint Programming Initiative on Antimicrobial Resistance/JPI-AMR/ZonMW # 547001008
Assistance Publique - Hôpitaux de Paris/US/United States/United States
Horizon 2020 Framework Programme/FAIR # 847786
Nederlandse Organisatie voor Wetenschappelijk Onderzoek/NACTAR ( # 16447)